Head-to-head · WeighScore
FormidableMD vs FuturHealth
By GLP-1 ScorecardUpdated
Score comparison
FormidableMD has the higher recorded score — 73.2/100 to 65.6/100.
FormidableMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormidableMD is a physician-led, cash-pay telehealth practice based in Florida offering GLP-1 weight-loss treatment — semaglutide and tirzepatide in both FDA-approved and compounded forms, plus oral options — alongside peptides, HRT/TRT, urgent care, labs, and nutrition coaching.
Before you choose
Before comparing the headline prices, the FormidableMD review and the FuturHealth review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, FormidableMD vs Genesis Health and FuturHealth vs GOAL.MD compare each of them with another graded program, and the list of alternatives to FormidableMD ranks the programs closest to FormidableMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | FormidableMD | FuturHealth |
|---|---|---|
| WeighScore | 73.2/100 | 65.6/100 |
| Grade | C | C |
| Site position | #78 | #235 |
| Semaglutide | $169/mo (1 mg dose, compounded) | $198/mo (Wegovy pill intro dose) |
| Tirzepatide | $199/mo (10 mg dose, compounded) | $395/mo (Zepbound KwikPen intro dose) |
| Coverage | 1 state | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
- Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
- Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible
What to consider
- Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
- Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
- The 503A compounding pharmacy partner is not named on the site
Strengths
- Names the brand and format on its introductory price cards.
- Publishes its subscription cancellation and refund terms.
What to consider
- Introductory figures leave continuing and all-in charges open.
- The membership guarantee excludes medication and most third-party charges.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.